表紙:小児用ワクチンの世界市場規模:ワクチンタイプ、用途、技術、地域別の予測(2022年~2028年)
市場調査レポート
商品コード
1077566

小児用ワクチンの世界市場規模:ワクチンタイプ、用途、技術、地域別の予測(2022年~2028年)

Global Pediatric Vaccines Market Size study, by Vaccine Type, by Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella, and Other Applications), by Technology and Regional Forecasts 2022-2028

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
小児用ワクチンの世界市場規模:ワクチンタイプ、用途、技術、地域別の予測(2022年~2028年)
出版日: 2022年05月17日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の小児用ワクチンの市場規模は、2021年に約478億米ドルとなり、2022年~2028年の間の予測期間中に8.3%以上の好調な成長率で成長すると予測されています。

小児人口の増加が市場の成長を促進し、肺炎・喘息・水痘などの小児疾患の高い有病率も市場全体を牽引すると期待されます。また、ワクチンの研究開発の増大、疾病の負担軽減への政府支援、ワクチン投与経路の開発などが、予測期間中の市場成長を高める見通しです。しかし、遠隔地へのワクチンのアクセス性の低さや、ワクチンの高コストが、2022年~2028年の間の予測期間中の市場成長を妨げると予測されます。

当レポートでは、世界の小児用ワクチン市場について調査分析し、市場動向、競合情勢、セグメント別・地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の小児用ワクチン市場の定義と範囲

第3章 世界の小児用ワクチン市場力学

  • 小児用ワクチン市場影響分析(2020年~2028年)

第4章 世界の小児用ワクチン市場業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価:COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の小児用ワクチン市場:ワクチンタイプ別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析:ワクチンタイプ別
  • 市場推計と予測:ワクチンタイプ別(2018年~2028年)
  • サブセグメント分析
    • 一価
    • 多価

第7章 世界の小児用ワクチン市場:用途別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析:用途別
  • 市場推計と予測:用途別(2018年~2028年)
  • サブセグメント分析
    • 肺炎球菌感染症
    • インフルエンザ
    • はしか、おたふく風邪、風疹(MMR)
    • その他の用途

第8章 世界の小児用ワクチン市場:技術別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析:技術別
  • 市場推計と予測:技術別(2018年~2028年)
  • サブセグメント分析
    • 弱毒生
    • 不活性
    • トキソイド
    • 結合型
    • その他の技術

第9章 世界の小児用ワクチン市場:地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • 主要な市場戦略
  • 企業プロファイル
    • GlaxoSmithKline Plc.
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Sanofi S.A.
    • Panacea Biotec
    • Zydus Cadila
    • Emergent BioSolutions Inc.
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Indian Immunologicals Ltd.

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Pediatric Vaccines Market, report scope
  • TABLE 2. Global Pediatric Vaccines Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Pediatric Vaccines Market estimates & forecasts by Vaccine Type 2018-2028 (USD Billion)
  • TABLE 4. Global Pediatric Vaccines Market estimates & forecasts by Application 2018-2028 (USD Billion)
  • TABLE 5. Global Pediatric Vaccines Market estimates & forecasts by Technology 2018-2028 (USD Billion)
  • TABLE 6. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Pediatric Vaccines Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Pediatric Vaccines Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. U.S. Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. Canada Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. Canada Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. UK Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. UK Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. Germany Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. Germany Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. RoE Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. RoE Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. China Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. China Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. India Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. India Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. Japan Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. Japan Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. Brazil Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Brazil Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Mexico Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Mexico Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. RoLA Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. RoLA Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row Pediatric Vaccines Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. Row Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. Row Pediatric Vaccines Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Pediatric Vaccines Market
  • TABLE 56. List of primary sources, used in the study of global Pediatric Vaccines Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Pediatric Vaccines Market, research methodology
  • FIG 2. Global Pediatric Vaccines Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Pediatric Vaccines Market, key trends 2021
  • FIG 5. Global Pediatric Vaccines Market, growth prospects 2022-2028
  • FIG 6. Global Pediatric Vaccines Market, porters 5 force model
  • FIG 7. Global Pediatric Vaccines Market, pest analysis
  • FIG 8. Global Pediatric Vaccines Market, value chain analysis
  • FIG 9. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Pediatric Vaccines Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Pediatric Vaccines Market, regional snapshot 2018 & 2028
  • FIG 15. North America Pediatric Vaccines Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Pediatric Vaccines Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia Pacific Pediatric Vaccines Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Pediatric Vaccines Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Pediatric Vaccines Market, company market share analysis (2021)
目次

Global Pediatric Vaccines Market is valued at approximately USD 47.8 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2028. Pediatric Vaccines trigger the body's immune system to produce the requisite antibodies to protect infants from various diseases such as polio, pneumonia, and influenza. These vaccines are necessary to develop resistance to infections caused by these pathogens. An increase in the pediatric population is driving the market growth. For instance, according to the World Bank, the birth rate, (per 1,000 people) increased from 17.888 in 2019 to 17.982 in 2020. Furthermore, the total market is also expected to be driven by the high prevalence of pediatric diseases such as pneumonia, asthma, chickenpox, and others. According to the World Health Organization, in 2019, pneumonia causes 14% of all deaths of children under 5 years old, killing 740 180 children. Also, increasing R&D in vaccines, government support to reduce burden of diseases, and developments in the route of vaccine administration are likely to increase the market growth during the forecast period. However, low accessibility of vaccines to remote areas and high cost of vaccines impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Pediatric Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to the well-established healthcare infrastructure and wide commercial availability of vaccines. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate over the forecast period 2022-2028 due to favorable government initiatives regarding vaccine development and awareness and increasing number of diseases.

Major market players included in this report are:

GlaxoSmithKline Plc.

Merck & Co., Inc.

Pfizer Inc.

Sanofi S.A.

Panacea Biotec

Zydus Cadila

Emergent BioSolutions Inc.

Serum Institute of India Pvt. Ltd.

Bharat Biotech

Indian Immunologicals Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Vaccine Type:

Monovalent

Multivalent

By Application:

Pneumococcal Disease

Influenza

Measles, Mumps and Rubella (MMR)

Other Applications

By Technology:

Live Attenuated

Inactivated

Toxoid

Conjugate

Other Technologies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Pediatric Vaccines Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Pediatric Vaccines Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Pediatric Vaccines Market, by Vaccine Type, 2020-2028 (USD Billion)
    • 1.2.3. Pediatric Vaccines Market, by Application, 2020-2028 (USD Billion)
    • 1.2.4. Pediatric Vaccines Market, by Technology, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pediatric Vaccines Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pediatric Vaccines Market Dynamics

  • 3.1. Pediatric Vaccines Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing pediatric population
      • 3.1.1.2. High prevalence of pediatric diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. Low accessibility of vaccines to remote areas
      • 3.1.2.2. High cost of vaccines
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing R&D in vaccines
      • 3.1.3.2. Developments in the route of vaccine administration

Chapter 4. Global Pediatric Vaccines Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Pediatric Vaccines Market, by Vaccine Type

  • 6.1. Market Snapshot
  • 6.2. Global Pediatric Vaccines Market by Vaccine Type, Performance - Potential Analysis
  • 6.3. Global Pediatric Vaccines Market Estimates & Forecasts by Vaccine Type, 2018-2028 (USD Billion)
  • 6.4. Pediatric Vaccines Market, Sub Segment Analysis
    • 6.4.1. Monovalent
    • 6.4.2. Multivalent

Chapter 7. Global Pediatric Vaccines Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Pediatric Vaccines Market by Application, Performance - Potential Analysis
  • 7.3. Global Pediatric Vaccines Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
  • 7.4. Pediatric Vaccines Market, Sub Segment Analysis
    • 7.4.1. Pneumococcal Disease
    • 7.4.2. Influenza
    • 7.4.3. Measles, Mumps and Rubella (MMR)
    • 7.4.4. Other Applications

Chapter 8. Global Pediatric Vaccines Market, by Technology

  • 8.1. Market Snapshot
  • 8.2. Global Pediatric Vaccines Market by Technology, Performance - Potential Analysis
  • 8.3. Global Pediatric Vaccines Market Estimates & Forecasts by Technology, 2018-2028 (USD Billion)
  • 8.4. Pediatric Vaccines Market, Sub Segment Analysis
    • 8.4.1. Live Attenuated
    • 8.4.2. Inactivated
    • 8.4.3. Toxoid
    • 8.4.4. Conjugate
    • 8.4.5. Other Technologies

Chapter 9. Global Pediatric Vaccines Market, Regional Analysis

  • 9.1. Pediatric Vaccines Market, Regional Market Snapshot
  • 9.2. North America Pediatric Vaccines Market
    • 9.2.1. U.S. Pediatric Vaccines Market
      • 9.2.1.1. Vaccine Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Technology breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Pediatric Vaccines Market
  • 9.3. Europe Pediatric Vaccines Market Snapshot
    • 9.3.1. U.K. Pediatric Vaccines Market
    • 9.3.2. Germany Pediatric Vaccines Market
    • 9.3.3. France Pediatric Vaccines Market
    • 9.3.4. Spain Pediatric Vaccines Market
    • 9.3.5. Italy Pediatric Vaccines Market
    • 9.3.6. Rest of Europe Pediatric Vaccines Market
  • 9.4. Asia-Pacific Pediatric Vaccines Market Snapshot
    • 9.4.1. China Pediatric Vaccines Market
    • 9.4.2. India Pediatric Vaccines Market
    • 9.4.3. Japan Pediatric Vaccines Market
    • 9.4.4. Australia Pediatric Vaccines Market
    • 9.4.5. South Korea Pediatric Vaccines Market
    • 9.4.6. Rest of Asia Pacific Pediatric Vaccines Market
  • 9.5. Latin America Pediatric Vaccines Market Snapshot
    • 9.5.1. Brazil Pediatric Vaccines Market
    • 9.5.2. Mexico Pediatric Vaccines Market
  • 9.6. Rest of The World Pediatric Vaccines Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. GlaxoSmithKline Plc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Merck & Co., Inc.
    • 10.2.3. Pfizer Inc.
    • 10.2.4. Sanofi S.A.
    • 10.2.5. Panacea Biotec
    • 10.2.6. Zydus Cadila
    • 10.2.7. Emergent BioSolutions Inc.
    • 10.2.8. Serum Institute of India Pvt. Ltd.
    • 10.2.9. Bharat Biotech
    • 10.2.10. Indian Immunologicals Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption